Knowledge, Attitudes, and Perceptions of Hidradenitis Suppurativa Among the General Population of Saudi Arabia

Abstract

Background and Aims: Hidradenitis Suppurativa (HS) is a chronic skin condition causing pain, abscesses, and psychological distress, impacting the quality of life. This study examines the Saudi population’s knowledge, attitudes, and perceptions to address gaps, improve care, and enhance public health. Methods: This cross-sectional study was conducted from October 2023 to January 2024, and it surveyed 597 Saudi adults (≥18 years) using a validated self-administered questionnaire. Data were analyzed with SPSS version 22.0, summarizing categorical variables as frequencies and continuous data as means. Chi-square and t-tests assessed knowledge and attitude differences, with significance set at p ≤ 0.05. Results: The study included 597 participants, most aged 18–25 years (63.8%) and predominantly female (71.9%). Self-reported Hidradenitis Suppurativa (HS) was present in 6.5% of participants. Knowledge of HS varied, with 93.8% recognizing its hereditary nature, yet only 45.7% understanding the need for dermatological intervention. Common misconceptions included those related to hygiene and self-treatment. Participants with personal connections to HS, particularly family members, and female participants demonstrated significantly greater knowledge and more positive attitudes toward the condition (p < 0.05). Favorable attitudes were also significantly higher among females. Conclusion: The study emphasizes the significance of educational interventions to raise awareness about Hidradenitis Suppurativa in Saudi Arabia. Such initiatives can facilitate early detection, enhance patient care, and implement effective public health strategies for improved management of chronic diseases.

References

1. 1.Mohammed AlQurashi S, Khalid Al- Sadi K, Damanhori N. Knowledge and Practices about Recognition and Treatment of Hidradenitis Suppurativa and Associated Factors in Primary Healthcare among Family Medicine Residents. 2022;(1):350–61.
2. 2.Alsadhan H, Alfawzan AI, Yaqoub A, Almoneef A, Almohideb M. Hidradenitis Suppurativa: Estimated Prevalence, Clinical Features, and Risk Factors in Riyadh, Saudi Arabia. Cureus. 2022;14(3).
3. 3.Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol. 2020;82(5):1045–58.
4. 4.Nguyen T V, Damiani G, Orenstein LA V, Hamzavi I, Jemec GB. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life.J Eur Acad Dermatology Venereol. 2021;35(1):50–61.
5. 5.Elkin K, Daveluy S, Avanaki K. Hidradenitis suppurativa: Current understanding, diagnostic and surgical challenges, and developments in ultrasound application. Ski Res Technol. 2020;26(1):11–9.
6. 6.Alikhan A,Sayed C,Alavi A,Alhusayen R, Brassard A, Burkhart C, et al. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.J Am 14 Majmaah Journal of Health Sciences,Vol.13, Issue4, October-2025,Rabi-Al-thani-1447 Knowledge,Attitudes,and PerceptionsofHidradenitisSuppurativaAmongtheGeneralPopulationofSaudiArabia Acad Dermatol. 2019;81(1):76–90.
7. 7.Hendricks AJ, Hsiao JL, Lowes MA, Shi VY. A comparison of international management guidelines for hidradenitis suppurativa. Dermatology. 2021;237(1):81–96.
8. 8.Orenstein LA V, Nguyen T V, Damiani G, Sayed C, Jemec GBE, Hamzavi I. Medical and surgical management of hidradenitis suppurativa: a review of international treatment guidelines and implementation in general dermatology practice. Dermatology. 2020;236(5):393–412.